TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan · Delayed Price · Currency is TWD 9.09
-0.06 (-0.66%)
Oct 31, 2025, 2:32 PM CST
TPEX:4157 Market Cap
TPEX:4157 has a market cap or net worth of 6.53 billion as of October 31, 2025. Its market cap has decreased by -38.58% in one year.
Market Cap
6.53B
Enterprise Value
5.70B
Revenue
40.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.09
Market Cap Chart
Since September 5, 2013, TPEX:4157's market cap has decreased from 42.07B to 6.53B, a decrease of -84.49%. That is a compound annual growth rate of -14.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 6.53B | -20.61% |
| Dec 31, 2024 | 8.22B | -24.67% |
| Dec 29, 2023 | 10.91B | -5.16% |
| Dec 30, 2022 | 11.51B | 4.22% |
| Dec 30, 2021 | 11.04B | -32.60% |
| Dec 31, 2020 | 16.38B | 24.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |